ClinicalTrials.gg
Enrolling by invitationNCT06595914EDucateUpdated Oct 30, 2026

Improving In-hospital and Post-discharge Patient Education for Mild Traumatic Brain Injury

An interventional study of Clinical implementation strategies in Concussion, Mild and Traumatic Brain Injury, sponsored by Medical College of Wisconsin. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by Medical College of Wisconsin · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
5,831
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to develop and validate ways to provide better patient education and clinical management for individuals who go to the emergency department (ED) with concussion or mild traumatic brain injury (mTBI).

Read the detailed description

The study will address three aims: (1) identify factors that help and hinder providing in-ED education to patients with mTBI prior to discharge; (2) examine the impact of tailored implementation strategies on ED providers' provision of in-ED patient education; and (3) evaluate the impact of providing patient education in the ED and through a mobile Health (mHealth) tool post-discharge on patient-level outcomes after mTBI.

02

Conditions studied

  • Concussion, Mild
  • Traumatic Brain Injury

Keywords

  • Education
  • Systems of care
  • Emergency department
  • Implementation science
03

In context

Brain Concussion

637 studies on the registry are indexed under Brain Concussion; 163 are open to participants now.

This study's planned enrollment of 5,831 is above the median of 63 across 446 interventional studies indexed under Brain Concussion.

Browse Brain Concussion studies →

Lead sponsor

Medical College of Wisconsin is the lead sponsor of 548 studies on the registry; 122 are open to participants now.

Of its 75 completed or terminated interventional studies of FDA-regulated products, 57 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

ED clinicians:

  • Faculty attending physician, advanced practice professional (APP), resident, fellow, or nurse who practices in an eligible Froedtert \& Medical College of Wisconsin (MCW) emergency department

Patients-Survey Cohort:

  • Seen and discharged from a Froedtert \& MCW emergency department.
  • Age 18 or older.
  • Has a clinical diagnosis of TBI, as reflected by a relevant International Classification of Disease-10th Edition (ICD-10) code or other evidence (e.g., diagnosis and educational information in the After Visit Summary)
  • Speaks English or Spanish.

Patients-Chart Review Only:

  • Seen and discharged from a Froedtert \& MCW emergency department.
  • Age 18 or older.
  • Has a clinical diagnosis of TBI, as reflected by a relevant ICD-10 code or other evidence (e.g., diagnosis and educational information in the After Visit Summary). Note that for evaluation of Secondary Aim #1 (% trauma patients with an mTBI diagnosis), a broader sample of emergency department patients evaluated for trauma will be evaluated).

Exclusion criteria

Exclusion Criteria:

ED clinicians:

  • Providers that do not practice in a Froedtert \& Medical College of Wisconsin emergency department.

Patients-Survey Cohort.

  • In protective custody.
  • On psychiatric hold.
  • Is not own decision maker (e.g., activated healthcare power of attorney).
  • Indicated Do Not Contact in their research contact preferences.
  • Left the emergency department prematurely (e.g., against medical advice).
  • History of serious health condition that, in the opinion of the investigator, would interfere with engagement in or validity of the survey (e.g., active thought disorder; terminal cancer; dementia).

Patients-Chart Review Only:

  • Minors under the age of 18.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Single group
Masking
Single (Participant)
Enrollment
5,831 participants (estimated)

Study arms

  • Experimental
    Clinicians

    Clinician participants will all have access to any clinical implementation strategies that are developed and disseminated in the project.

    Other: Clinical implementation strategies

  • No intervention
    Patients-Survey Cohort

    Patient participants will be observationally followed via survey during the study to monitor patient-reported outcomes.

  • No intervention
    Patients-Chart Review Only

    Patients who are not in the survey study but who meet other eligibility criteria will undergo chart review to provide electronic health record-based outcomes.

Interventions

  • OtherClinical implementation strategies

    Clinical implementation strategies, selected based on ED clinician survey/interview findings from Aim 1 using the Implementing Promoting Action on Research Implementation in Health Services (i-PARIHS) implementation science framework

06

What researchers measure

Primary outcomes

  1. Change in patient-level penetration-electronic health record (EHR)

    Change in the percentage of concussion/mTBI-related encounters for which an mTBI patient handout was documented in the Epic After Visit Summary (Aim 2 outcome)

    Time frame: Pre-intervention baseline period (estimated study onset to 1 year later); post- intervention follow-up period (estimated 18 months from study onset to 1 year later)

  2. Change in patient-level penetration-patient reported outcome (PRO)

    Change in the percentage of concussion/mTBI-related encounters for which patients reported having received mTBI patient education before ED discharge (Aim 2 outcome)

    Time frame: Pre-intervention baseline period (estimated study onset to 1 year later); post- intervention follow-up period (estimated 18 months from study onset to 1 year later)

  3. Self-efficacy to manage mTBI symptoms

    Patient ratings on the Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v1.0 - Self-Efficacy for Managing Symptoms, a 20-point scale based on 4 Likert-type items with 5 response options each (higher scores = more confidence) (Aim 3 outcome).

    Time frame: Day 1 post-ED visit, Day 30 post-ED visit

  4. mTBI symptom burden

    Patient-rated Rivermead Post Concussion Symptoms Questionnaire total score (range 0-64; higher scores = more severe injury-related symptoms) (Aim 3 outcome).

    Time frame: Day 1 post-ED visit, Day 30 post-ED visit

Secondary outcomes

  1. Change in percentage of trauma cases resulting in mTBI diagnosis

    Change in the percentage of ED encounters for a traumatic injury resulting in a diagnosis of concussion or mTBI

    Time frame: Pre-intervention baseline period (estimated study onset to 1 year later); post-intervention follow-up period (estimated 18 months from study onset to 1 year later)

  2. Patient-rated mTBI knowledge

    Patient-rated mTBI knowledge, measured with a 24-item True/False scale (total score range 0-24; higher scores = greater knowledge). Questions ask about common and uncommon mTBI symptoms and common misconceptions about mTBI signs and recovery.

    Time frame: Day 30 post-ED visit

  3. Patient-rated clinical care satisfaction at Day 1

    Collected on a 5-point scale with the options Very Satisfied, Somewhat Satisfied, Neither Satisfied Nor Dissatisfied, Somewhat Dissatisfied, and Very Dissatisfied. The question is "How satisfied are you with the care you received for head injury in the Emergency Department?"

    Time frame: Day 1 post-ED visit

  4. Patient-rated clinical care satisfaction at Day 30

    Collected on a 5-point scale with the options Very Satisfied, Somewhat Satisfied, Neither Satisfied Nor Dissatisfied, Somewhat Dissatisfied, and Very Dissatisfied. The question is "How satisfied are you with the care you received for head injury since leaving the emergency department?"

    Time frame: Day 30 post-ED visit

Other outcomes

  1. Change in clinician ratings to the Acceptability of Intervention Measure

    ED clinician responses to the Acceptability of Intervention Measure (AIM), a 4 item scale with 5-point Likert-type items scaled from 1 (completely disagree) to 5 (completely agree). Total scores reflect the mean item rating (range 1 to 5); higher scores reflect greater acceptability. (Aim 2 outcome; Aim 1 will characterize pre-implementation baseline data only)

    Time frame: Pre-intervention survey period (study onset through roughly 6 months later); post- intervention survey period (roughly 18 months from study onset to 6 months later)

  2. Change in clinician ratings to the Intervention Appropriateness Measure

    ED clinician responses to the Intervention Appropriateness Measure (IAM), a 4 item scale with 5-point Likert-type items scaled from 1 (completely disagree) to 5 (completely agree). Total scores reflect the mean item rating (range 1 to 5); higher scores reflect greater appropriateness. (Aim 2 outcome; Aim 1 will characterize pre-implementation baseline data only)

    Time frame: Pre-intervention survey period (study onset through roughly 6 months later); post- intervention survey period (roughly 18 months from study onset to 6 months later)

  3. Change in clinician ratings to the Feasibility of Intervention Measure

    ED clinician responses to the Feasibility of Intervention Measure (FIM), a 4 item scale with 5-point Likert-type items scaled from 1 (completely disagree) to 5 (completely agree). Total scores reflect the mean item rating (range 1 to 5); higher scores reflect greater feasibility. (Aim 2 outcome; Aim 1 will characterize pre-implementation baseline data only)

    Time frame: Pre-intervention survey period (study onset through roughly 6 months later); post- intervention survey period (roughly 18 months from study onset to 6 months later)

07

Study locations

1 site
08

References and documents

Publications

  • King NS, Crawford S, Wenden FJ, Moss NE, Wade DT. The Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms commonly experienced after head injury and its reliability. J Neurol. 1995 Sep;242(9):587-92. doi: 10.1007/BF00868811. PubMed 8551320 ↗
  • Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017 Aug 29;12(1):108. doi: 10.1186/s13012-017-0635-3. PubMed 28851459 ↗

Individual participant data

Plan to share: Yes — De-identified raw data for the Patient-Survey Cohort will be made available on the Open Data Commons for Traumatic Brain Injury (ODC-TBI)

09

Updates

1 registry update since Sep 25, 2026
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date
1 update, last Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    Minor edits only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06595914
Collaborators
U.S. Army Medical Research Acquisition Activity, Ohio State University, University of Kentucky
Responsible party
Lindsay Nelson (Professor, Medical College of Wisconsin) — Principal investigator
First posted
Sep 19, 2024
Start date
Sep 11, 2024
Primary completion
May 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Oct 30, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion